sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> cancer therapeutics market

report

Cancer Therapeutics Market, by Types (Prostate Cancer, Blood Cancer, Lung Cancer, Skin Cancer, Gastrointestinal Cancer, Breast Cancer, Others), by Therapy (Chemotherapy, Hormonal, Immunotherapy, Targeted Therapy, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC123 October 2016 100+ FREE 10% CUSTOMIZATION

Global Cancer Therapeutics Market worth USD 100.67 billion in 2016 and expected to reach USD 170.63 billion by 2022, at a CAGR of 9.2% from 2016 to 2022.

The objective of this report is to describe the market trends and revenue forecasts for the cancer therapeutics market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the cancer therapeutics market. The scope of this report covers the cancer therapeutics market by its major segments, which include the types, therapies, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the key factors propelling the growth of the global market
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Granular analysis of the current market scenario and the expected market growth

KEY PREMIUM INDUSTRY INSIGHTS

  • The increasing prevalence of cancer, rising popularity of biologics, patent expirations of the popular drugs, and the rising impact of biosimilars are the key factors fuelling the growth of the cancer therapeutics market.
  • The key initiatives taken by the European Union (EU) and the United States Food and Drug Administration (US FDA) to provide pre-market approvals for the promising cancer therapies are fuelling the market for the cancer therapy.
  • However, the factors such as huge research & development cost, the threat of failure, adverse effects of cancer therapy, and stringent regulatory are the major restraints for the cancer therapeutics market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s cancer therapeutics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the cancer therapeutics market by the following segments:

  • Cancer Therapeutics Market, by Types
    • Prostate Cancer
    • Blood Cancer
    • Lung Cancer
    • Skin Cancer
    • Gastric Cancer
    • Breast Cancer
    • Other Cancer Types
  • Cancer Therapeutics Market, by Therapy
    • Chemotherapy
    • Hormonal Therapy
    • Immunotherapy
    • Targeted Therapy
    • Other Therapies

KEY MARKET PLAYERS

Key players in the cancer therapeutics market include:

  • F. Hoffmann-La Roche
  • Sanofi SA
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Novartis AG
  • Eli Lilly and Company
  • Celgene Corporation

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Cancer Therapeutics Market

TRENDING RELATED REPORT

Prescription Pharmaceuticals Market, by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020


  1. MARKET OVERVIEW
    1. Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Promising Pipeline Therapeutics
    2. Value Chain Analysis
    3. Key Approvals
  5. CANCER THERAPEUTICS MARKET, BY TYPES
    1. Segment Share
    2. By Types
      1. Prostate Cancer
      2. Blood Cancer
      3. Lung Cancer
      4. Skin Cancer
      5. Gastric Cancer
      6. Breast Cancer
      7. Other Cancer Types
  6. CANCER THERAPEUTICS MARKET, BY THERAPY
    1. Segment Share
    2. By Therapy
      1. Chemotherapy
      2. Hormonal Therapy
      3. Immunotherapy
      4. Targeted Therapy
      5. Other Therapies
  7. CANCER THERAPEUTICS MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Canada
      2. By Types
      3. By Therapy
    2. Europe
      1. By Country
        1. Germany
        2. United Kingdom
        3. France
        4. Rest of Europe
      2. By Types
      3. By Therapy
    3. Asia-Pacific
      1. By Country
        1. India
        2. Japan
        3. China
        4. Rest of Asia-Pacific
      2. By Types
      3. By Therapy
    4. Rest of the World
      1. By Country
        1. Latin America
        2. The Middle East & Africa
      2. By Types
      3. By Therapy
  8. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
  9. KEY MARKET PLAYERS
    1. F. Hoffmann-La Roche
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Sanofi SA
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. GlaxoSmithKline plc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Johnson & Johnson Services, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Amgen Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Merck & Co., Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Pfizer Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Eli Lilly and Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Celgene Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us